Royal Society of Chemistry, Dalton Transactions, 35(45), p. 13671-13674
DOI: 10.1039/c6dt02456d
Full text: Unavailable
A novel cobalt(iii)-triazole system was developed for hypoxia-activated drug delivery with an [O2]-dependent reduction to cobalt(ii) followed by ligand dissociation.